Granulomatous lung disease: clinical aspects

Expert Rev Respir Med. 2020 Oct;14(10):1045-1063. doi: 10.1080/17476348.2020.1794827. Epub 2020 Sep 2.

Abstract

Introduction: Granulomatous lung diseases (GLD) are heterogeneous group of diseases that can be broadly categorized as infectious or noninfectious. This distinction is extremely important, as the misdiagnosis of a GLD can have serious consequences. In this manuscript, we describe the clinical manifestations, histopathology, and diagnostic approach to GLD. We propose an algorithm to distinguish infectious from noninfectious GLD.

Areas covered: We have searched PubMed and Medline database from 1950 to December 2019, using multiple keywords as described below. Major GLDs covered include those caused by mycobacteria and fungi, sarcoidosis, hypersensitivity pneumonitis, and vasculidities.

Expert opinion: The cause of infectious GLD is usually identified through microbiological culture and molecular techniques. Most noninfectious GLD are diagnosed by clinical and laboratory criteria, often with exclusion of infectious pathogens. Further understanding of the immunopathogenesis of the granulomatous response may allow improved diagnosis and treatment of GLD.

Keywords: mycobacterium tuberculosis; Granulomatous lung disease; chronic beryllium disease; diagnosis; fungal infections; granulomatous polyangiitis; hypersensitivity pneumonitis and vasculidities; non-tubercular mycobacterium; sarcoidosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alveolitis, Extrinsic Allergic
  • Granuloma / diagnosis
  • Granuloma / pathology
  • Granuloma / physiopathology*
  • Humans
  • Lung Diseases / diagnosis
  • Lung Diseases / pathology
  • Lung Diseases / physiopathology*
  • Mycobacterium Infections
  • Mycoses
  • Sarcoidosis
  • Vasculitis